Evidence map›Paper›PMID 24665382›Full record

ArticleTissue barriers2013

S-nitrosation of proteins: An emergent regulatory mechanism in microvascular permeability and vascular function.

Fabiola A Sánchez, Ingrid P Ehrenfeld, Walter N Durán

Open access · hybridAbstract read
In one paragraph

Article in Tissue barriers, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 14 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. S-nitrosylation regulates VE-cadherin phosphorylation and internalization in microvascular permeability.American journal of physiology. Heart and circulatory physiology · 2016
    Article
  6. Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 2 countries.

Fabiola A SánchezInstituto de Inmunología; Universidad Austral de Chile; Valdivia, Chile.
Ingrid P EhrenfeldHistología y Patología; Universidad Austral de Chile; Valdivia, Chile.
Walter N DuránDepartment of Pharmacology and Physiology; New Jersey Medical School; University of Medicine and Dentistry of New Jersey; Newark, NJ USA.
Austral University of Chile · CLRutgers, The State University of New Jersey · US

Funding

CONTROL OF MICROCIRCULATORY EXCHANGE FUNCTIONR01HL070634 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DURAN, WALTER N. · 2002 to 2012
$3.6M
Inactivation of hyperpermeability after ischemia-reperfusion induced inflammationR01HL088479 · NHLBI · UNIV OF MED/DENT OF NJ-NJ MEDICAL SCHOOL · PI DURAN, WALTER N. · 2008 to 2012
$1.9M
NHLBI NIH HHS R01 HL070634NHLBI NIH HHS R01 HL088479
6 · The paper itself

Abstract

Nitric oxide (NO) is a key factor in inflammation as it regulates microvascular permeability, leukocyte adhesion and wound healing. This mini-review addresses mainly spatial and temporal requirements of NO regulatory mechanisms, with special emphasis on S-nitrosation. Endothelial nitric oxide synthase (eNOS)-derived NO induces S-nitrosation of p120 and β-catenin, particularly in response to platelet-activating factor (PAF), and through traffic and interactions at the adherens junction promotes endothelial hyperpermeability. S-nitrosation is a determinant in vascular processes such as vasodilation and leukocyte-endothelium interactions. Interestingly, NO decreases leukocytes adhesion to endothelium, but the mechanisms are unknown. Advances in NO molecular biology and regulation may serve as a basis for the development of new therapeutic strategies in the treatment of diseases characterized by inflammation such as ischemia-reperfusion injury, stroke, cancer and atherosclerosis.

Indexed as

adherens junctioneNOSmicrovascular permeabilitynitric oxideS-nitrosation

Identifiers

PMID24665382
PMCPMC3875611
OpenAlexW2046165696

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.